At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- American Gastroenterological Association Collaborates with Scope Forward to Launch GI Mastermind Virtual, a New Professional Development Program Focused on Structural Change in Gastroenterology
- The 53 most innovative companies in healthcare (Advisory Board)
- Delaying DOAC after colonoscopy: Weighing the risks (MDedge)
- Practice-changing takeaways from the 2026 Gut Microbiota Summit: A clinical reality check (MDLinx)
- ‘Phenomenal’ Tech May Boost Adenoma Detection in Colonoscopy (Medscape)
- CEO of America’s largest public hospital system says he’s ready to replace radiologists with AI (Radiology Business)
- OpenEvidence and Tandem Partner to Streamline Evidence-Based Prescribing and Prior Authorizations (Business Wire)
- Where GI training may fall short (Becker’s GI & Endoscopy)
